Robert Mahoney's most recent trade in Axcelis Technologies Inc was a trade of 573 Common Stock done at an average price of $86.6 . Disclosure was reported to the exchange on March 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axcelis Tech Inc | Robert John Mahoney | EVP Global Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.58 per share. | 02 Mar 2026 | 573 | 14,633 (0%) | 0% | 86.6 | 49,610 | Common Stock |
| Axcelis Tech Inc | Robert John Mahoney | EVP Global Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2026 | 1,734 | 15,206 (0%) | 0% | 0 | Common Stock | |
| Comera Life Sciences Holdings | Robert Mahoney | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 14 Aug 2023 | 20,000 | 124,576 | - | 0.6 | 12,504 | Common Stock |
| Comera Life Sciences Holdings | Robert Mahoney | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Purchase) |